November 26, 2014 2:12 PM ET

Biotechnology

Company Overview of RNL Europe GmbH

Company Overview

As of 2013, RNL Europe GmbH went out of business. RNL Europe GmbH operates as a research organization that develops stem cell-based therapies for the treatment of autoimmune disorders. The company was formerly known as Pharmicell Europe GmbH and changed its name to RNL Europe GmbH, following its acquisition by K-STECMCELL CO.,Ltd. in January 2011. RNL Europe GmbH was founded in 2006 and is based in Berlin, Germany.

Friedrichstr. 147

Berlin,  10117

Germany

Founded in 2006

Phone:

49 30 3393 5994

Fax:

49 30 3393 5996

Key Executives for RNL Europe GmbH

RNL Europe GmbH does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Activaero GmbH Europe
GOT Therapeutics GmbH Europe
Biotechnology Research and Information Network AG Europe
Ovamed GmbH Europe
P.A.L.M. Microlaser Technologies GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RNL Europe GmbH, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.